We are live on ! Find out more
MMRF

Michelson Medical Research Foundation Portfolio holdings

AUM $108M
1-Year Est. Return 29.95%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+29.95%
3 Year Est. Return
+52.22%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$99.8M
AUM Growth
-$15.2M
Cap. Flow
-$17.3M
Cap. Flow %
-17.35%
Top 10 Hldgs %
78.3%
Holding
22
New
2
Increased
–
Reduced
–
Closed
2
Avg Time Held
7.6 quarters
Top 10 Avg Time Held
5.4 quarters
Top 20 Avg Time Held
5.6 quarters

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$10.2M
2
RGR icon
Sturm, Ruger & Co
RGR
+$2.13M

Sector Composition

Rank Sector Weight
1 Miscellaneous 58.78%
2 Consumer Discretionary 11.45%
3 Healthcare 9.93%
4 Financials 9.37%
5 Real Estate 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MTN icon
1
Vail Resorts
MTN
$5.03B
$11.4M 11.45%
86,000
– –
2024 Q3
5 quarters
IVE icon
2
iShares S&P 500 Value ETF
IVE
$48.6B
$11M 11.03%
51,905
– –
2022 Q4
12 quarters
UNH icon
3
UnitedHealth
UNH
$334B
$9.9M 9.93%
+30,000
New +$10.2M
2025 Q4
0 quarters
VEA icon
4
Vanguard FTSE Developed Markets ETF
VEA
$232B
$9.88M 9.9%
158,160
– –
2022 Q4
12 quarters
DBRG
5
DELISTED
DigitalBridge
DBRG
$9.35M 9.37%
609,500
– –
2025 Q2
2 quarters
VWO icon
6
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$6.86M 6.88%
127,630
– –
2022 Q4
12 quarters
IBB icon
7
iShares Biotechnology ETF
IBB
$10.5B
$5.92M 5.94%
35,095
– –
2022 Q4
12 quarters
IWC icon
8
iShares Micro-Cap ETF
IWC
$1.4B
$5.58M 5.59%
35,385
– –
2023 Q3
9 quarters
KRE icon
9
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
$4.12M 4.13%
63,510
– –
2023 Q3
9 quarters
SAFE
10
Safehold
SAFE
$854M
$4.07M 4.08%
297,477
– –
2025 Q2
2 quarters
MANU icon
11
Manchester United
MANU
$3.46B
$3.18M 3.19%
200,000
– –
2025 Q1
3 quarters
EWW icon
12
iShares MSCI Mexico ETF
EWW
$1.52B
$2.9M 2.91%
41,850
– –
2023 Q3
9 quarters
VB icon
13
Vanguard Morningstar Small-Cap ETF
VB
$78B
$2.84M 2.85%
11,010
– –
2023 Q3
9 quarters
EWZ icon
14
iShares MSCI Brazil ETF
EWZ
$8.88B
$2.58M 2.59%
81,300
– –
2023 Q3
9 quarters
EWY icon
15
iShares MSCI South Korea ETF
EWY
$27.5B
$1.96M 1.96%
20,155
– –
2023 Q3
9 quarters
RGR icon
16
Sturm, Ruger & Co
RGR
$709M
$1.88M 1.88%
+57,500
New +$2.13M
2025 Q4
0 quarters
EWT icon
17
iShares MSCI Taiwan ETF
EWT
$12.7B
$1.74M 1.75%
27,435
– –
2023 Q3
9 quarters
EWJ icon
18
iShares MSCI Japan ETF
EWJ
$23.6B
$1.62M 1.63%
20,100
– –
2023 Q3
9 quarters
GXC icon
19
State Street SPDR S&P China ETF
GXC
$448M
$1.62M 1.63%
16,750
– –
2023 Q4
8 quarters
CRGY icon
20
Crescent Energy
CRGY
$4.42B
$1.31M 1.31%
156,166
– –
2022 Q4
12 quarters
GDX icon
21
VanEck Gold Miners ETF
GDX
$26.1B
– –
-234,305
Closed -$17.9M –
SGOV icon
22
iShares 0-3 Month Treasury Bond ETF
SGOV
$111B
– –
-116,226
Closed -$11.7M –

Similar funds

Michelson Medical Research Foundation's Q4 2025 Portfolio in Review

As of Q4 2025, Michelson Medical Research Foundation held 22 positions worth $99.8M, down 13% from $115M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Michelson Medical Research Foundation withdrew a net $17.3M in Q4 2025, closing 2 positions. Its most notable exit was VanEck Gold Miners ETF, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, down from 75% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Michelson Medical Research Foundation opened a new position in UnitedHealth worth $9.9M.

  • Michelson Medical Research Foundation's largest Q4 2025 buy was UnitedHealth: 30,000 shares worth $9.9M.
  • Michelson Medical Research Foundation fully exited VanEck Gold Miners ETF in Q4 2025, selling an estimated $17.9M.
  • Michelson Medical Research Foundation's ten largest holdings make up 78% of its $99.8M portfolio in Q4 2025.
  • Michelson Medical Research Foundation opened 2 new positions and closed 2 in Q4 2025.
  • Michelson Medical Research Foundation's portfolio value fell 13% quarter-over-quarter to $99.8M.

Based on Michelson Medical Research Foundation's 13F filing for Q4 2025, filed 17 Feb 2026.